Cytochrome P-450 2D6 Isoenzyme

Aka: Cytochrome P-450 2D6 Isoenzyme, CYP2D6, CYP2D6 Inducer, CYP2D6 Inhibitor, CYP2D6 Substrate

advertisement

II. Background

  1. Accounts for 2-5% of hepatic P-450 isoenzymes

III. Precautions: CYP2D6 Deficiency or poor metabolizers (5-10%)

  1. See Pharmacogenetics
  2. Populations with CYP2D6 deficiency (poor metabolizers)
    1. Occurs in 7% of white persons
  3. Consequences of CYP2D6 Deficiency
    1. Exaggerated physiologic response to substrate medications listed below
    2. No response to Codeine or Tramadol (not metabolized to active form)
    3. Fluoxetine and Nortriptyline risk of toxicity
    4. Amitriptyline, Nortriptyline, Paroxetine risk of toxicity (reduce starting dose by 50%)
    5. Aripiprazole (Abilify) risk of toxicity (reduce starting dose)
    6. Atomoxetine (Strattera) risk of toxicity (reduce starting dose)
  4. References
    1. Ingelman-Sundberg (2005) Pharmacogenomics J 5:6-13 [PubMed]

IV. Precautions: CYP2D6 Ultrarapid metabolizers (1-2%)

  1. See Pharmacogenetics
  2. Populations with CYP2D6 ultrarapid metabolization (fast metabolizers)
    1. Occurs in 5% of caucasians and african americans
    2. Occurs in 30% of arabs or North Africans
  3. Consequences of CYP2D6 ultrarapid metabolization
    1. Amitriptyline, Nortriptyline, Paroxetine with reduced response (consider other agents)
    2. Increased Codeine metabolization to Morphine
      1. Also effects Hydrocodone, Oxycodone and Tramadol
      2. Risk of Opioid induced respiratory depression and other Overdose adverse effects
      3. Children are especially susceptible (deaths have occurred)
      4. Deaths in children have occurred with codeine Analgesics following Tonsillectomy and adenoidectomy
      5. Resulted in FDA black box warning in 2013
  4. References
    1. (2013) Presc Lett 20(4): 21
    2. FDA Drug Safety Communication
      1. http://www.fda.gov/Drugs/DrugSafety/ucm339112.htm

V. Interactions: Metabolized by CYP2D6 (Substrates)

  1. Neuropsychiatric drugs
    1. Tricyclics
      1. Amitriptyline (Elavil)
      2. Desipramine (Norpramin)
      3. Imipramine
      4. Paroxetine (Paxil)
      5. Nortriptyline (Pamelor)
      6. Trimipramine (Surmontil)
    2. Antipsychotics
      1. Perphenazine (Trilafon)
      2. Risperidone (Risperdal)
      3. Haloperidol (Haldol)
      4. Thioridazine (Mellaril)
    3. Neurologic
      1. Donepezil (Aricept)
  2. Cardiopulmonary Drugs
    1. Beta Blockers
      1. Carvedilol (Coreg)
      2. Metoprolol (Lopressor)
      3. Propranolol (Inderal)
      4. Timolol
      5. Water soluble Beta-Blockers not hepatic metabolized
        1. May not be affected by CYP2D6 system
        2. Examples: Sotalol, Nadolol, Atenolol
    2. 1C Antiarrhythmics
      1. Encainide
      2. Flecainide
      3. Mexiletine
      4. Propafenone
  3. Analgesics
    1. Codeine
    2. Dextromethorphan
    3. Oxycodone
    4. Hydrocodone
    5. Tramadol (Ultram)

VI. Interactions: Inhibitor of CYP2D6

  1. Neuropsychiatric drugs
    1. Haloperidol (Haldol)
    2. Thioridazine (Mellaril)
    3. Fluoxetine (Prozac)
    4. Paroxetine (Paxil)
  2. Cardiopulmonary Drugs
    1. Amiodarone
    2. Quinidine
  3. Antibiotics
    1. Ritonavir
    2. Terbinafine (Lamisil)
  4. Miscellaneous
    1. Celecoxib (Celebrex)
    2. Cimetidine
    3. Diphenhydramine (Benadryl)

VII. Interactions: Inducer of CYP2D6

  1. Neuropsychiatric drugs
    1. Fluoxetine (Prozac)
    2. Paroxetine (Paxil)
  2. Cardiopulmonary Drugs
    1. Quinidine
    2. Amiodarone
  3. Antibiotics
    1. Ritonavir
  4. Miscellaneous
    1. Cimetidine

Images: Related links to external sites (from Bing)

These images are a random sampling from a Bing search on the term "Cytochrome P-450 2D6 Isoenzyme." Click on the image (or right click) to open the source website in a new browser window. Search Bing for all related images

Related Studies

Related Topics in Metabolic Disorders

advertisement